Report Detail

Other Global Montelukast Sodium Market Growth 2019-2024

  • RnM3064544
  • |
  • 06 March, 2019
  • |
  • Global
  • |
  • 162 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The major raw material for montelukast sodium is 7-chloroquinaldine, isophthalaldehyde, etc. On the global market, supply of raw materials is relatively full. Fluctuations in the price of the upstream product will impact on the production cost of montelukast sodium industry.
We tend to believe this industry is an emerging industry, and the consumption increasing degree will show a rapid growth curve. For product prices, the slow downward trend in recent years will maintain in the future as competition intensifies. Besides, prices gap between different brands will go narrowing gradually. Also, there will be fluctuation in gross margin.

According to this study, over the next five years the Montelukast Sodium market will register a 12.1% CAGR in terms of revenue, the global market size will reach US$ 390 million by 2024, from US$ 190 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Montelukast Sodium business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium market by product type, application, key manufacturers and key regions and countries.

This study considers the Montelukast Sodium value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tablets
Chewable Tablet
Oral Solution

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Groups
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Montelukast Sodium consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Montelukast Sodium market by identifying its various subsegments.
Focuses on the key global Montelukast Sodium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Montelukast Sodium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Montelukast Sodium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Montelukast Sodium Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Montelukast Sodium Consumption 2014-2024
        • 2.1.2 Montelukast Sodium Consumption CAGR by Region
      • 2.2 Montelukast Sodium Segment by Type
        • 2.2.1 Montelukast Sodium Amorphous
        • 2.2.2 Montelukast Sodium Crystalline
      • 2.3 Montelukast Sodium Consumption by Type
        • 2.3.1 Global Montelukast Sodium Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Montelukast Sodium Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Montelukast Sodium Sale Price by Type (2014-2019)
      • 2.4 Montelukast Sodium Segment by Application
        • 2.4.1 Tablets
        • 2.4.2 Chewable Tablet
        • 2.4.3 Oral Solution
      • 2.5 Montelukast Sodium Consumption by Application
        • 2.5.1 Global Montelukast Sodium Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Montelukast Sodium Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Montelukast Sodium Sale Price by Application (2014-2019)

      3 Global Montelukast Sodium by Players

      • 3.1 Global Montelukast Sodium Sales Market Share by Players
        • 3.1.1 Global Montelukast Sodium Sales by Players (2017-2019)
        • 3.1.2 Global Montelukast Sodium Sales Market Share by Players (2017-2019)
      • 3.2 Global Montelukast Sodium Revenue Market Share by Players
        • 3.2.1 Global Montelukast Sodium Revenue by Players (2017-2019)
        • 3.2.2 Global Montelukast Sodium Revenue Market Share by Players (2017-2019)
      • 3.3 Global Montelukast Sodium Sale Price by Players
      • 3.4 Global Montelukast Sodium Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Montelukast Sodium Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Montelukast Sodium Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Montelukast Sodium by Regions

      • 4.1 Montelukast Sodium by Regions
        • 4.1.1 Global Montelukast Sodium Consumption by Regions
        • 4.1.2 Global Montelukast Sodium Value by Regions
      • 4.2 Americas Montelukast Sodium Consumption Growth
      • 4.3 APAC Montelukast Sodium Consumption Growth
      • 4.4 Europe Montelukast Sodium Consumption Growth
      • 4.5 Middle East & Africa Montelukast Sodium Consumption Growth

      5 Americas

      • 5.1 Americas Montelukast Sodium Consumption by Countries
        • 5.1.1 Americas Montelukast Sodium Consumption by Countries (2014-2019)
        • 5.1.2 Americas Montelukast Sodium Value by Countries (2014-2019)
      • 5.2 Americas Montelukast Sodium Consumption by Type
      • 5.3 Americas Montelukast Sodium Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Montelukast Sodium Consumption by Countries
        • 6.1.1 APAC Montelukast Sodium Consumption by Countries (2014-2019)
        • 6.1.2 APAC Montelukast Sodium Value by Countries (2014-2019)
      • 6.2 APAC Montelukast Sodium Consumption by Type
      • 6.3 APAC Montelukast Sodium Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Montelukast Sodium by Countries
        • 7.1.1 Europe Montelukast Sodium Consumption by Countries (2014-2019)
        • 7.1.2 Europe Montelukast Sodium Value by Countries (2014-2019)
      • 7.2 Europe Montelukast Sodium Consumption by Type
      • 7.3 Europe Montelukast Sodium Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Montelukast Sodium by Countries
        • 8.1.1 Middle East & Africa Montelukast Sodium Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Montelukast Sodium Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Montelukast Sodium Consumption by Type
      • 8.3 Middle East & Africa Montelukast Sodium Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Montelukast Sodium Distributors
      • 10.3 Montelukast Sodium Customer

      11 Global Montelukast Sodium Market Forecast

      • 11.1 Global Montelukast Sodium Consumption Forecast (2019-2024)
      • 11.2 Global Montelukast Sodium Forecast by Regions
        • 11.2.1 Global Montelukast Sodium Forecast by Regions (2019-2024)
        • 11.2.2 Global Montelukast Sodium Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Montelukast Sodium Forecast by Type
      • 11.8 Global Montelukast Sodium Forecast by Application

      12 Key Players Analysis

      • 12.1 Morepen Laboratories
        • 12.1.1 Company Details
        • 12.1.2 Montelukast Sodium Product Offered
        • 12.1.3 Morepen Laboratories Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Morepen Laboratories News
      • 12.2 Mylan
        • 12.2.1 Company Details
        • 12.2.2 Montelukast Sodium Product Offered
        • 12.2.3 Mylan Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Mylan News
      • 12.3 TAPI
        • 12.3.1 Company Details
        • 12.3.2 Montelukast Sodium Product Offered
        • 12.3.3 TAPI Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 TAPI News
      • 12.4 MSN Laboratories
        • 12.4.1 Company Details
        • 12.4.2 Montelukast Sodium Product Offered
        • 12.4.3 MSN Laboratories Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 MSN Laboratories News
      • 12.5 Ultratech India
        • 12.5.1 Company Details
        • 12.5.2 Montelukast Sodium Product Offered
        • 12.5.3 Ultratech India Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Ultratech India News
      • 12.6 Aurobindo Pharma
        • 12.6.1 Company Details
        • 12.6.2 Montelukast Sodium Product Offered
        • 12.6.3 Aurobindo Pharma Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Aurobindo Pharma News
      • 12.7 Hetero Labs
        • 12.7.1 Company Details
        • 12.7.2 Montelukast Sodium Product Offered
        • 12.7.3 Hetero Labs Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Hetero Labs News
      • 12.8 Unimark Remedies
        • 12.8.1 Company Details
        • 12.8.2 Montelukast Sodium Product Offered
        • 12.8.3 Unimark Remedies Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Unimark Remedies News
      • 12.9 Jubilant Cadista
        • 12.9.1 Company Details
        • 12.9.2 Montelukast Sodium Product Offered
        • 12.9.3 Jubilant Cadista Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Jubilant Cadista News
      • 12.10 Aamorb Pharmaceuticals
        • 12.10.1 Company Details
        • 12.10.2 Montelukast Sodium Product Offered
        • 12.10.3 Aamorb Pharmaceuticals Montelukast Sodium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Aamorb Pharmaceuticals News
      • 12.11 Sudarshan Groups
      • 12.12 Ortin Laboratories
      • 12.13 Vamsi Labs
      • 12.14 Adley Group
      • 12.15 Medopharm
      • 12.16 Hengyuan Pharmaceutical
      • 12.17 Arromax Pharmaceutical Technology
      • 12.18 Lihe Wuhan New Chemical Materials
      • 12.19 Shanghai Huachu Chemical

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Montelukast Sodium . Industry analysis & Market Report on Montelukast Sodium is a syndicated market report, published as Global Montelukast Sodium Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Montelukast Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,876.76
      4,315.14
      5,753.52
      3,374.52
      5,061.78
      6,749.04
      575,315.40
      862,973.10
      1,150,630.80
      305,353.80
      458,030.70
      610,707.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report